GSA CAPITAL PARTNERS LLP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$249,000
+13.7%
30,247
-9.5%
0.03%0.0%
Q2 2022$219,000
+0.5%
33,410
-5.2%
0.03%
+50.0%
Q3 2021$218,000
+26.7%
35,232
+5.3%
0.02%
-77.1%
Q2 2020$172,000
-47.7%
33,447
-63.2%
0.10%
+17.1%
Q1 2020$329,00090,9720.08%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,986,176$12,275,0002.58%
Worth Venture Partners, LLC 454,364$2,808,0001.26%
Opaleye Management Inc. 455,600$2,816,0000.53%
J. Goldman & Co LP 1,663,229$10,279,0000.52%
X-Square Capital, LLC 92,283$570,0000.30%
NEA Management Company, LLC 3,952,958$24,429,0000.29%
Birchview Capital, LP 40,000$247,0000.17%
PERSONAL CFO SOLUTIONS, LLC 23,000$142,0000.03%
PURA VIDA INVESTMENTS, LLC 147,574$912,0000.03%
GSA CAPITAL PARTNERS LLP 35,232$218,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders